Pre-Transplant MRD Predicts Outcome Following Reduced-Intensity and Myeloablative Allogeneic Hemopoietic SCT in AML
Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2014.9
Full Text
Open PDFAbstract
Available in full text
Date
February 10, 2014
Authors
Publisher
Springer Science and Business Media LLC